Edition:
United States

Tetraphase Pharmaceuticals Inc (TTPH.OQ)

TTPH.OQ on NASDAQ Stock Exchange Global Select Market

2.32USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
192,860
52-wk High
$6.97
52-wk Low
$2.06

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 22 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 6 6 6 6
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 3.19 6.00 1.81 1.00
Quarter Ending Mar-19 3 2.66 3.20 1.92 --
Year Ending Dec-18 7 16.84 20.50 8.00 8.08
Year Ending Dec-19 7 21.68 39.50 12.00 29.00
Earnings (per share)
Quarter Ending Dec-18 5 -0.34 -0.19 -0.48 -0.55
Quarter Ending Mar-19 3 -0.31 -0.18 -0.50 --
Year Ending Dec-18 7 -1.40 -1.05 -1.82 -2.04
Year Ending Dec-19 7 -1.18 -0.77 -2.00 -1.53

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 2.18 11.58 9.39 429.93
Quarter Ending Mar-18 1.90 1.89 0.01 0.73
Quarter Ending Dec-17 2.41 2.53 0.12 4.79
Quarter Ending Sep-17 1.33 4.07 2.74 206.02
Quarter Ending Jun-17 1.67 1.59 0.08 4.96

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3.19 3.86 3.76 3.63 1.00
Quarter Ending Mar-19 2.66 2.66 3.22 2.80 --
Year Ending Dec-18 16.84 17.32 17.25 15.56 8.08
Year Ending Dec-19 21.68 23.41 25.49 24.83 29.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 1 1
Quarter Ending Mar-19 0 0 0 1
Year Ending Dec-18 0 1 1 1
Year Ending Dec-19 0 1 0 2
Earnings